Circle Safe manufactures medical devices that provide solutions for diaphragmatic paralysis, a condition affecting breathing rhythm. Their products aim to improve respiratory function for patients with this specific type of paralysis.
Funding
$8.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cryoballoon ablation, a common procedure for treating atrial fibrillation, carries a risk of damaging the phrenic nerve, leading to diaphragmatic paralysis. This paralysis impairs breathing and can significantly impact a patient's quality of life.
Solution
Circle Safe is developing a medical device solution designed to prevent diaphragmatic paralysis during cryoballoon ablation procedures. Their technology aims to eliminate the risk of phrenic nerve injury, thereby improving patient safety and outcomes. By preventing this complication, Circle Safe's device allows for safer and more effective treatment of atrial fibrillation using cryoballoon ablation.
Target Audience
The primary target audience includes electrophysiologists and cardiologists performing cryoballoon ablation procedures for atrial fibrillation, as well as hospitals and clinics offering these treatments.
Features
- Device designed specifically to mitigate phrenic nerve damage during cryoballoon ablation.
- Aims to eliminate diaphragmatic paralysis as a complication of the procedure.